▸ hk ipo decoder

IPO · 2026-05-19

Redemption Rights in Pre-IPO Funding: Valuation Adjustment Mechanism Financial Pressure

The SFC’s 2024-25 annual enforcement report, published in April 2025, recorded a 35% year-on-year increase in inquiries related to pre-IPO funding structures, specifically those involving redemption rights embedded in valuation adjustment mechanisms (VAMs). This surge is not coincidental. As the HKEX Main Board processed 72 new listing applications in Q1 2025 — a 28% increase over Q1 2024 — sponsors and auditors flagged an unprecedented number of redemption clauses that, if triggered, would reclassify equity as debt under HKFRS 9. The financial reporting implications are severe: a single redemption event can wipe out a pre-IPO company’s net equity position overnight, forcing a restatement of historical financials and delaying the listing timetable by 6-12 months. For CFOs and company secretaries navigating the 2025-26 pipeline, the distinction between a “clean” redemption right and a “poisonous” one is the difference between a successful listing and an aborted one.

The Mechanics of Redemption Rights in Pre-IPO VAMs

Redemption rights in pre-IPO funding are contractual provisions that grant investors the option to demand the issuer repurchase their shares at a predetermined price, typically the original investment amount plus an accrued return of 8-15% per annum. These clauses sit within broader VAMs, which also include performance-based equity adjustments and anti-dilution protections. The core financial risk arises from HKAS 32 Financial Instruments: Presentation, which mandates that a financial instrument be classified as a liability if the issuer does not have an unconditional right to avoid delivering cash or another financial asset.

The Liability Classification Trigger

Under HKAS 32.18, a redemption right that is exercisable at the investor’s discretion — or upon an event outside the issuer’s control — creates a present obligation for the issuer. This classification recharacterises the entire investment from equity to a financial liability on the balance sheet. For a company planning an IPO, this reclassification can reduce reported net assets by 30-60%, depending on the size of the pre-IPO round. Data from the HKEX’s 2024 Listing Committee Report showed that 14 of the 22 rejected or withdrawn applications in that year cited “material uncertainty related to redemption obligations” as a primary reason for the sponsor’s inability to issue an unmodified opinion under HKSA 570 Going Concern.

The Accretion of Financial Cost

Once classified as a liability, the redemption amount must be measured at amortised cost using the effective interest method under HKFRS 9. This means the issuer must recognise an annual finance cost equal to the difference between the redemption price and the initial proceeds, spread over the expected holding period. For a typical Series B investment of HKD 200 million with a 5-year redemption term and a 12% annual return, the annual finance charge is approximately HKD 24 million. Over three years, this accumulates to HKD 72 million in recognised finance costs — a direct hit to profit or loss that can turn a profitable pre-IPO company into a reporting loss-maker. The 2023 SFC Consultation Paper on Pre-IPO Investments explicitly warned that such charges “may render the issuer unable to meet the profit test under HKEX Listing Rule 8.05(1).”

Structural Variants and Their Balance Sheet Impact

Not all redemption rights are created equal. The financial outcome hinges on three variables: the trigger event, the redemption price formula, and the issuer’s ability to settle in equity rather than cash.

Investor-Triggered vs. Event-Triggered Redemption

An investor-triggered redemption — where the investor can demand repurchase at any time after a specified date (e.g., 5 years from closing) — almost always results in liability classification under HKAS 32. The issuer has no control over the exercise date. Conversely, an event-triggered redemption tied to a failed IPO (e.g., “if the issuer does not complete a listing within 4 years”) is more nuanced. If the issuer can demonstrate that the IPO failure is unlikely, auditors may accept equity classification. However, the HKEX’s Listing Decision LD43-3 (2023) clarified that the burden of proof rests with the sponsor to demonstrate a “high probability” of IPO completion within the contractual timeframe. In practice, this requires a detailed timeline, signed underwriting commitments, and a track record of regulatory filings — evidence that few pre-IPO companies can provide 12-18 months before the intended listing.

The “Clean” Redemption: Mandatory Conversion to Equity

The only structure that reliably avoids liability classification is a mandatory conversion clause that converts the redemption right into a fixed number of ordinary shares upon a pre-defined event, with no cash alternative. Under HKAS 32.16, this qualifies as an equity instrument because the issuer can settle by issuing a fixed number of its own equity instruments. The 2024 SFC Guidance Note on Pre-IPO Investments explicitly endorsed this structure, stating that “a redemption right that automatically converts into a fixed number of ordinary shares upon a qualified IPO will not be classified as a financial liability.” However, the conversion ratio must be fixed at inception — any variable ratio linked to the IPO price would reintroduce liability treatment under HKFRS 9.BC4.172.

The Hybrid Trap: Cash-or-Share Election

A common but dangerous variant is the “cash-or-share” redemption, where the issuer has the option to settle in either cash or shares. Under HKAS 32.26, if the issuer’s settlement option is not fixed — for example, if the share count depends on the fair value at settlement — the instrument remains a liability. The 2023 HKEX Listing Committee Review noted that 8 of the 12 rejected applications that year contained cash-or-share redemption clauses that sponsors had initially classified as equity. The Committee’s ruling forced restatements that delayed listings by an average of 9 months.

The Sponsors’ Due Diligence and Disclosure Obligations

The sponsor’s role under the SFC Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (paragraph 17.2) is to ensure that all material redemption rights are fully disclosed in the prospectus and that the financial statements reflect the correct classification. Failure to do so exposes the sponsor to regulatory action. In 2024, the SFC fined two sponsors a combined HKD 18 million for inadequate due diligence on pre-IPO redemption clauses that were later found to be misclassified.

The Going Concern Assessment

Under HKSA 570, the sponsor must evaluate whether the issuer can meet its redemption obligations if triggered. If the redemption amount exceeds the issuer’s cash reserves by a material margin — for example, HKD 500 million in redemption liabilities against HKD 80 million in cash — the auditor must issue a material uncertainty related to going concern (MUCG) paragraph. Data from the HKEX’s 2024 Annual Review of Listing Decisions showed that 19 of the 28 IPOs that received a MUCG paragraph in their prospectus saw their first-day share price decline by an average of 12.4%, compared to a 3.2% average gain for IPOs without such a paragraph.

Prospectus Disclosure Requirements

HKEX Listing Rule 11.07 requires that all material terms of pre-IPO investments, including redemption rights, be disclosed in the prospectus’s “History and Development” section. The disclosure must include: (1) the total amount raised; (2) the redemption price formula; (3) the trigger events; (4) the accounting classification; and (5) the impact on the issuer’s financial position. The 2024 SFC Enforcement Bulletin highlighted a case where an issuer omitted the redemption price formula, leading to a suspension of trading for 14 trading days and a subsequent fine of HKD 6 million against the issuer’s directors.

Actionable Takeaways for CFOs and Sponsors

  1. Conduct a redemption rights audit at the Series A stage, not at the pre-IPO stage, to avoid last-minute reclassifications that require restating three years of financials under HKFRS 9.

  2. Negotiate for a mandatory conversion to equity with a fixed conversion ratio at the time of investment, as this structure is the only one that guarantees equity classification under HKAS 32.16.

  3. Model the full amortised cost impact under HKFRS 9 for any redemption right that cannot be eliminated, and ensure the projected finance charges do not breach the profit test thresholds under HKEX Listing Rule 8.05(1).

  4. Secure a written confirmation from the auditor on the classification of each redemption right at least 12 months before the intended A1 filing, referencing HKAS 32 and HKFRS 9 by paragraph number.

  5. Disclose all redemption terms in the prospectus with the exact formula and trigger events, as omissions have been the basis for SFC enforcement actions and trading suspensions in 2024.